Shuttle Pharmaceuticals Holdings Inc (SHPH) Stock Price, Quote & News

Company Profile

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 240 403 4212

Website: www.shuttlepharma.com

Address:

401 Professional Drive, Suite 260, Gaithersburg, United States

EdyRustkal Aug. 19 at 2:23 AM

$SHPH Made a few grand here when i bought at 3.54 and sold at 4.50. Will be a buyer again if drops below the 3s.

0 · Reply

ace6th Aug. 18 at 2:24 PM

$SHPH Adding here should squeeze

0 · Reply

Zskylar Aug. 18 at 1:45 PM

$SHPH what happened to the supposedly squeeze here??

0 · Reply

JimmyOcarri Aug. 17 at 7:44 PM

$PSQH $SHPH $HAO $JEM $CHNR gemo

0 · Reply

Bazziggr Aug. 14 at 5:25 PM

$SHPH SXTC

0 · Reply

Palmerw1 Aug. 14 at 12:59 AM

$SHPH Is the special shareholder meeting a good thing?

0 · Reply

OnlyFibs Aug. 13 at 11:55 PM

$SHPH is waking up off the bottom! After building a strong base at the lower trendline support, price action on the 8hr view shows buyers stepping up and pushing through short-term moving averages. Structure is coiling right under local resistance for a potential momentum continuation move. 🐂 💧 Bull Key Level: $4.85 🐂 🔥 Bear Key Level: $3.58 🐻 ⚠️ Targets: $6.80 / $9.00 💰 🍺 Why: Reversal base combined with expanding MACD momentum creates a high-R/R breakout opportunity. #SHPH #stockmarket #swingtrade #technicalanalysis #hovdid

0 · Reply

LongLake88 Aug. 13 at 2:24 PM

$SHPH this stock moves on air, need more volume for short squeeze

0 · Reply

KTGAMBLESTOCKS Aug. 12 at 4:00 PM

$SHPH acquired some kind of data center campus. Under 3M market cap. $NBIS calls wow. $HIVE undervalued.

1 · Reply

ace6th Aug. 11 at 4:52 PM

$SHPH 73% Shorted, what a time for a squeeze to happen

0 · Reply

United Dogecoin Purchases Dogecoin Miners and Secures Renewable Energy Data Centre Site

Jun 25, 2026, 4:05 PM EDT - 7 weeks ago

United Dogecoin Advances Data Centre and Power Infrastructure Strategy to Support DOGE Mining and AI Hosting

2026-06-10T23:50:59.000Z - 2 months ago

Shuttle Pharmaceuticals Holdings Inc trading halted, news pending

Jun 9, 2026, 8:30 AM EDT - 2 months ago

Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 11, 2026, at 12:01 a.m., Eastern Time

May 14, 2026, 4:05 PM EDT - 3 months ago

Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs

May 7, 2026, 2:02 PM EDT - 3 months ago

E.F. Hutton & Co. Serves as Exclusive M&A Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin Miner

May 1, 2026, 8:41 AM EDT - 3 months ago

United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation

Apr 30, 2026, 4:05 PM EDT - 3 months ago

Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner

Mar 27, 2026, 8:00 AM EDT - 5 months ago

RETRANSMISSION: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

Mar 26, 2026, 4:05 PM EDT - 5 months ago

Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

Mar 12, 2026, 8:30 AM EDT - 5 months ago

E.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals' $3.5 Million Public Offering

Mar 6, 2026, 8:00 AM EST - 5 months ago

Shuttle Pharmaceuticals Announces $3.5 Million Public Offering

Jan 13, 2026, 4:00 PM EST - 7 months ago

Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ai's Drug Discovery Platform Matters More Than Ever

Nov 21, 2025, 9:30 AM EST - 9 months ago

Shuttle Pharmaceuticals Acquires AI Health Platform

2025-11-18T22:05:15.000Z - 9 months ago

Shuttle Pharmaceuticals files to sell 625,156 shares of common stock for holders

Nov 3, 2025, 7:00 AM EST - 10 months ago

Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00

Oct 22, 2025, 10:00 AM EDT - 10 months ago

Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH)

Oct 22, 2025, 7:00 AM EDT - 10 months ago

Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)

Oct 21, 2025, 5:55 PM EDT - 10 months ago

Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)

Oct 21, 2025, 4:05 PM EDT - 10 months ago

Shuttle Pharmaceuticals to Acquire AI Molecular Modeling and Predictive Analytics Platform

2025-10-10T14:25:15.000Z - 11 months ago

Shuttle Pharmaceuticals announces extension of LOI with Molecule.ai

Oct 10, 2025, 10:20 AM EDT - 11 months ago

Shuttle Executes LOI with Molecule.ai

2025-10-09T20:25:12.000Z - 11 months ago

Shuttle Pharmaceuticals to acquire Molecule.ai for $10M

Oct 9, 2025, 4:15 PM EDT - 11 months ago

Shuttle to Enter $3.24 Billion AI Pharmaceutical Market

Aug 14, 2025, 4:05 PM EDT - 1 year ago

Shuttle Pharma Provides Second Quarter 2025 Corporate Update

2025-08-05T10:16:04.000Z - 1 year ago

Shuttle Pharmaceuticals files to sell 1.18M shares of common stock for holders

Jun 24, 2025, 4:10 PM EDT - 1 year ago

Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market

Jun 20, 2025, 3:55 PM EDT - 1 year ago

Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market

2025-06-13T23:50:22.000Z - 1 year ago

Shuttle Pharmaceuticals Holdings Inc trading halted, news pending

2025-06-12T16:05:29.000Z - 1 year ago

Shuttle Pharmaceuticals says reverse stock split to become effective June 16

Jun 12, 2025, 12:00 PM EDT - 1 year ago

Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time

2025-06-12T12:45:38.000Z - 1 year ago

Shuttle Pharmaceuticals announces 25-for-1 proposed reverse stock split

Jun 12, 2025, 8:30 AM EDT - 1 year ago

Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative

2025-06-04T20:10:45.000Z - 1 year ago

Shuttle Pharmaceuticals appoints George Scorsis as chairman

Jun 4, 2025, 4:01 PM EDT - 1 year ago

Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors

2025-05-15T20:50:26.000Z - 1 year ago

Shuttle Pharma Ropidoxuridine Phase 2 trial nears 50% enrollment

May 15, 2025, 4:45 PM EDT - 1 year ago

Shuttle Pharma Provides Corporate Update

May 8, 2025, 4:01 PM EDT - 1 year ago

Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial

Apr 21, 2025, 4:15 PM EDT - 1 year ago

Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

2025-04-10T20:10:54.000Z - 1 year ago

Shuttle Pharmaceuticals files provisional patent application with USPTO

Apr 10, 2025, 4:01 PM EDT - 1 year ago

Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer

Mar 13, 2025, 4:10 PM EDT - 1 year ago

Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering

2025-03-12T13:30:38.000Z - 1 year ago

Shuttle Pharmaceuticals prices 19.17M shares at 30c per share in public offering

Mar 12, 2025, 9:24 AM EDT - 1 year ago

Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering

2025-03-12T10:25:28.000Z - 1 year ago

Shuttle Pharmaceuticals appoints Christopher Cooper as interim Co-CEO

Mar 12, 2025, 6:20 AM EDT - 1 year ago

Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities

Feb 26, 2025, 10:45 AM EST - 1 year ago

Shuttle Pharma Provides Corporate Update and Reports 2024 Results

2025-01-21T14:15:45.000Z - 1 year ago

Shuttle reaches milestone in enrollment for Phase 2 trial of Ropidoxuridine

Jan 7, 2025, 9:00 AM EST - 1 year ago

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

2024-12-19T14:11:32.000Z - 1 year ago

Shuttle Pharmaceuticals enters into sponsored research agreement with UCSF

2024-11-26T14:06:10.000Z - 1 year ago

Shuttle first patient enrollment, dosing in Phase 2 Ropidoxuridine line

Nov 26, 2024, 9:00 AM EST - 1 year ago

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient

Nov 13, 2024, 5:00 PM EST - 1 year ago

Shuttle Pharma Provides Third Quarter 2024 Corporate Update

2024-10-30T01:10:10.000Z - 1 year ago

Shuttle Pharmaceuticals prices $4.5M at-the-market offering at $1.525 per share

Oct 29, 2024, 9:05 PM EDT - 1 year ago

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Oct 28, 2024, 4:05 PM EDT - 1 year ago

Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Sep 16, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Sep 4, 2024, 4:15 PM EDT - 2 years ago

Shuttle Pharma Provides Second Quarter 2024 Corporate Update

Aug 26, 2024, 4:10 PM EDT - 2 years ago

Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)

Aug 14, 2024, 4:10 PM EDT - 2 years ago

Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

Jul 19, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma's Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE

Jun 18, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer

May 22, 2024, 4:15 PM EDT - 2 years ago

Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

May 14, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma Provides First Quarter 2024 Corporate Update

Apr 23, 2024, 4:15 PM EDT - 2 years ago

Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Apr 3, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024

Mar 22, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update

EdyRustkal Aug. 19 at 2:23 AM

$SHPH Made a few grand here when i bought at 3.54 and sold at 4.50. Will be a buyer again if drops below the 3s.

0 · Reply

ace6th Aug. 18 at 2:24 PM

$SHPH Adding here should squeeze

0 · Reply

Zskylar Aug. 18 at 1:45 PM

$SHPH what happened to the supposedly squeeze here??

0 · Reply

JimmyOcarri Aug. 17 at 7:44 PM

$PSQH $SHPH $HAO $JEM $CHNR gemo

0 · Reply

Bazziggr Aug. 14 at 5:25 PM

$SHPH SXTC

0 · Reply

Palmerw1 Aug. 14 at 12:59 AM

$SHPH Is the special shareholder meeting a good thing?

0 · Reply

OnlyFibs Aug. 13 at 11:55 PM

0 · Reply

LongLake88 Aug. 13 at 2:24 PM

$SHPH this stock moves on air, need more volume for short squeeze

0 · Reply

KTGAMBLESTOCKS Aug. 12 at 4:00 PM

$SHPH acquired some kind of data center campus. Under 3M market cap. $NBIS calls wow. $HIVE undervalued.

1 · Reply

ace6th Aug. 11 at 4:52 PM

$SHPH 73% Shorted, what a time for a squeeze to happen

0 · Reply

Bazziggr Aug. 10 at 3:04 PM

$SHPH SXTC

0 · Reply

KTGAMBLESTOCKS Aug. 7 at 5:52 PM

$SHPH run it

0 · Reply

takethemonayy Aug. 7 at 5:10 PM

$SHPH

0 · Reply

MillionaireTrader555 Aug. 7 at 12:00 PM

$SHPH only a matter of time before this goes $4 to $20+ extreme low floater that hasn’t run yet!

0 · Reply

Skywalker86 Aug. 6 at 6:20 PM

$SHPH shorts trying to take this down any type of buy volume flow will make this move fast

0 · Reply

TrustFundBaby Aug. 6 at 6:13 PM

$SHPH $ENSC $VMAR Called both SHPH AND ENSC 🚀🚀 GET READY FOR $HYFM 🔥😠

0 · Reply

STACKD0E Aug. 6 at 4:48 PM

$OESX $SHPH 🙃✨️

1 · Reply

serialdiluters Aug. 6 at 1:28 PM

$SHPH ran +26% yesterday. 2 424B filings YTD. https://serialdiluters.com/t/SHPH/

0 · Reply

SlutGopher Aug. 6 at 12:02 PM

$SHPH looks perplexing indeed

0 · Reply

FastTrader0 Aug. 6 at 3:44 AM

$SHPH this is gonna run tomorrow

1 · Reply

Bigeyes2 Aug. 6 at 3:20 AM

$SHPH cup and handle

0 · Reply

ace6th Aug. 5 at 11:19 PM

$SHPH The Borrow rate/fee is 400% +! + Micro Float! let her fly to $30.00 +

1 · Reply

Market Cap	2.61M
Revenue (ttm)	0.00
Net Income (ttm)	-11.72M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	12,283
Avg Vol	2,653,068
Day's Range	N/A - N/A
Shares Out	637,000.00
Stochastic %K	5%
Beta	0.20
Analysts	Strong Buy
Price Target	N/A